Organigram Holdings Inc. Announces Election of Directors

MONCTON, New Brunswick--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Corporation”) (TSX: OGI) (NASDAQ: OGI) announced today that each of the eight nominees listed in its management information circular dated January 23, 2020 (the “Circular”) was elected as a director of Organigram at the Annual and Special Meeting of Shareholders (the “Meeting”) held on February 25, 2020. The vote was conducted by a show of hands. Detailed results of the votes cast by proxy are set out below:

Nominee Votes For  

 

% of Votes
For
Votes
Withheld
% of Votes
Withheld

Peter Amirault

16,616,184

   

97.12

492,516

2.88

 

Greg Engel

16,625,303

   

97.18

483,397

2.83

 

Dexter John

16,078,699

   

93.98

1,030,001

6.02

 

Geoffrey Machum

16,611,530

   

97.09

497,170

2.91

 

Ken Manget

16,654,923

   

97.35

453,777

2.65

 

Sherry Porter

16,319,053

   

95.39

789,647

4.62

 

Stephen Smith

16,642,629

   

97.28

466,071

2.72

 

Derrick West

16,600,454

   

97.03

508,246

2.97

The biographies of the Corporation’s directors are set out in the Circular, which is available under the Corporation’s profile on SEDAR at www.sedar.com.

“On behalf of the board, I am delighted to welcome Geoffrey, Ken and Stephen to our team. They bring a robust set of knowledge, skills and experience, and they will complement our board as we continue to grow in a dynamic industry,” said Greg Engel, Organigram’s Chief Executive Officer. “We would also like to thank Mike Bourque, who did not stand for re-election, for his valuable contributions and service to the board over the past few years.”

Following the Meeting, the newly-elected board of directors of the Corporation (the “Board”) re-appointed Peter Amirault as Chairman of the Board. The Board also re-constituted its committees as follows:

  • Audit Committee: Stephen Smith (Chair), Dexter John, Ken Manget, and Derrick West
  • Governance and Nominating Committee: Geoffrey Machum (Chair), Sherry Porter, and Dexter John
  • Compensation Committee: Sherry Porter (Chair), Geoffrey Machum, and Ken Manget
  • Investment Committee: Dexter John (Chair), Ken Manget and Stephen Smith

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.

Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and Trailblazer. Organigram's facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

 

Contacts

For Investor Relations enquiries, please contact:
Amy Schwalm
Vice President, Investor Relations
Amy.Schwalm@organigram.ca
(416) 704-9057

For Media enquiries, please contact:
Ray Gracewood
Senior Vice President, Marketing and Communications
ray.gracewood@organigram.ca
(506) 645-1653

Sign up to get full access to all our latest press releases.

Sign Up